Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON41528
NL-OMON41528
Completed
Not Applicable

Clinical and neurobiological characterisation of muscarinic receptor-deficit schizophrenia (MRDS) - SMURF (Schizophrenia and MUscarinic Receptor Functioning)

Academisch Medisch Centrum0 sites90 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMRDSpsychosis10039628

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
MRDS
Sponsor
Academisch Medisch Centrum
Enrollment
90
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients with first\-episode psychosis as defined by the standardised criteria of the CASH
  • •\-Medication free
  • •\-Duration of untreated psychosis no more than 1 year.
  • •\-18 years and older

Exclusion Criteria

  • •\-Use of antipsychotics and anticholinergics
  • •\-Contraindications for MRI
  • •\-Severe neurological, endocrine or psychiatric disorders
  • •\-Pregnancy
  • •\-Current use of recreational drugs; participants must be abstinent of recreational drugs such as cannabis at least 4 weaks prior to participation.
  • •\-Tardive dyskinesia

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Schizophrenia and MUscarinic Receptor FunctioningPsychosisCognition
NL-OMON28658Academic Medical Center (AMC)90
Withdrawn
Not Applicable
Clinical and neurobiological characterisation of muscarinic receptor-deficit schizophrenia (MRDS)MRDSpsychosis10039628
NL-OMON38703niversiteit Maastricht90
Completed
Not Applicable
Study on pathophysiology and clinical features of intractable and rare hepatobiliary and pancreatic disease and prognosis after treatmentpancreaticobiliary maljunction
JPRN-UMIN000042732Osaka City University24
Not yet recruiting
Phase 1
Development and neurobiological investigation of a social-cognitive intervention for patients with schizophreniaF20-F29Schizophrenia, schizotypal and delusional disorders
DRKS00025907niversitätsklinikum Gießen und Marburg, Standort Marburg50
Completed
Not Applicable
Magnetoencephalographic study on neural basis of motivation to eatHealthy
JPRN-UMIN000029809Osaka City University Graduate School of Medicine20